The present invention is directed to compounds of Formula (I),
and to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.
本发明涉及式(I)化合物及其药学上可接受的盐,其合成以及作为Raf抑制剂的用途。
PYRAZOLE COMPOUNDS AND THEIR USE AS RAF INHIBITORS
申请人:Pfizer Inc.
公开号:EP2183243A2
公开(公告)日:2010-05-12
METHODS OF TREATING DISEASES CHARACTERIZED BY EXCESSIVE WNT SIGNALLING
申请人:The Walter and Eliza Hall
Institute of Medical Research
The present invention is directed to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.